Two New Specialist Assays Launched for use on the IDS-ISYS and IGF-I Cleared for Sale in the USA
Immunodiagnostic Systems Holdings plc, a leading producer of diagnostic testing kits for the clinical and research markets, announces the launch of two new automated assays for use on the IDS-iSYS Immunoassay System.
- Ostase® Bone Specific Alkaline Phosphatase (BAP) assay
- Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) assay
These launches bring the IDS-iSYS product range to a total of 9 specialist immunoassays.
Clearance has been received from the US Food and Drugs Administration (FDA) for the IDS-iSYS IGF-I controls, enabling the automated IGF-I assay to be sold in the USA.